Question 1

How does psilocybin work in the brain?

Accepted Answer

Psilocybin is a prodrug that the body rapidly converts to psilocin, which acts primarily as an agonist at 5-HT2A serotonin receptors in the brain. This binding increases neural connectivity and alters default mode network activity, producing characteristic psychedelic effects. Research suggests this mechanism promotes neuroplasticity and may help disrupt rigid thought patterns associated with depression and PTSD. Evidence level: C (preliminary clinical evidence).

Question 2

Can you take psilocybin mushrooms with antidepressants?

Accepted Answer

SSRIs and other antidepressants can significantly reduce psilocybin's effects due to serotonin receptor downregulation. Conversely, MAOIs may dangerously potentiate effects and increase serotonin syndrome risk. Case reports document seizure risk when combining psilocybin with lithium. Individuals taking psychiatric medications should only use psilocybin in clinical settings with proper medical oversight and medication tapering protocols. Evidence level: C (case reports and pharmacological evidence).

Question 3

What is the therapeutic dose of psilocybin mushrooms?

Accepted Answer

Clinical trials for depression typically administer 10-25mg synthetic psilocybin, roughly equivalent to 1-3 grams of dried Psilocybe cubensis, though potency varies significantly between specimens. Traditional Mazatec healing ceremonies historically used similar amounts. Therapeutic outcomes depend heavily on preparation, setting, and integration support. Dosage should only be determined within clinical trial protocols or legal therapeutic frameworks. Evidence level: C (preliminary clinical evidence).

Question 4

Is psilocybin safe during pregnancy and breastfeeding?

Accepted Answer

Psilocybin is unsafe during pregnancy and breastfeeding. No adequate human studies exist, but animal research suggests potential fetal risks. The cardiovascular effects, including increased heart rate and blood pressure, pose additional pregnancy concerns. Psilocybin may also affect uterine smooth muscle. Women who are pregnant, planning pregnancy, or breastfeeding should avoid psilocybin entirely. Evidence level: D (expert opinion based on pharmacological properties).

Question 5

Who should not take psilocybin mushrooms?

Accepted Answer

Psilocybin is contraindicated for individuals with personal or family history of psychosis, schizophrenia, or bipolar disorder due to increased risk of triggering psychotic episodes. Those with severe cardiovascular disease face risks from elevated heart rate and blood pressure. The substance is also contraindicated during pregnancy. Clinical trial screening protocols systematically exclude these populations for safety reasons. Evidence level: C (clinical exclusion criteria and case reports).

Sacred Mushroom Psilocybin

Sources & Citations

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources